Literature DB >> 14279121

RENAL INVOLVEMENT IN ACTIVE "JUVENILE" CIRRHOSIS.

H SILVA, E W HALL, K R HILL, S SHALDON, S SHERLOCK.   

Abstract

Twelve patients with active ;juvenile' cirrhosis (active chronic hepatitis, ;lupoid' hepatitis) and six subjects with other types of portal or postnecrotic cirrhosis were submitted to percutaneous renal biopsy. In addition, renal function was assessed in all patients by measurement of the 24-hour endogenous creatinine clearance, maximal urinary osmolality after deprivation of water, 24-hour urinary protein excretion, and routine urine analysis. Renal function was not significantly abnormal in either group of patients, but seven of the 12 patients with active ;juvenile' cirrhosis showed mild histological changes on renal biopsy. These changes are very similar to the lesions described in early ;lupus nephritis'.The significance of these findings in relation to the aetiology of active ;juvenile' cirrhosis is discussed.

Entities:  

Keywords:  ADOLESCENCE; ASPARTATE AMINOTRANSFERASE; GERIATRICS; HEPATITIS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS, POSTNECROTIC

Mesh:

Substances:

Year:  1965        PMID: 14279121      PMCID: PMC472857          DOI: 10.1136/jcp.18.2.157

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Further obervations on hepatitis and cirrhosis in young women with positive clot tests for lupus erythematousus.

Authors:  L G BARTHOLOMEW; J C CAIN; A H BAGGENSTOSS; A B HAGEDORN
Journal:  Gastroenterology       Date:  1960-12       Impact factor: 22.682

2.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

3.  Studies on the character and staining of fibrin.

Authors:  A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

4.  The membranous and proliferative glomerulonephritis of hepatic cirrhosis.

Authors:  E R FISHER; H R HELLSTROM
Journal:  Am J Clin Pathol       Date:  1959-07       Impact factor: 2.493

5.  Liver disease in young women with hyperglobulinemia.

Authors:  W A JONES; B CASTLEMAN
Journal:  Am J Pathol       Date:  1962-03       Impact factor: 4.307

6.  Plasma-cell hepatitis, with special attention to steroid therapy.

Authors:  A R PAGE; R A GOOD
Journal:  AMA J Dis Child       Date:  1960-03

7.  Lupus nephritis: a clinical and pathologic study based on renal biopsies.

Authors:  R C MUEHRCKE; R M KARK; C L PIRANI; V E POLLAK
Journal:  Medicine (Baltimore)       Date:  1957-02       Impact factor: 1.889

8.  Biopsy of kidney in prone position.

Authors:  R M KARK; R C MUEHRCKE
Journal:  Lancet       Date:  1954-05-22       Impact factor: 79.321

9.  The coexistence of cirrhosis of the liver and glomerulonephritis; report of 14 cases.

Authors:  A J PATEK; D SEEGAL; M BEVANS
Journal:  Am J Med Sci       Date:  1951-01       Impact factor: 2.378

10.  Chronic liver disease in young people. Clinical features and course in thirty-three patients.

Authors:  R G WILLOCX; K J ISSELBACHER
Journal:  Am J Med       Date:  1961-02       Impact factor: 4.965

View more
  6 in total

Review 1.  Chronic hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

2.  Chronic active hepatitis and Graves' disease.

Authors:  W G Thompson; I R Hart
Journal:  Am J Dig Dis       Date:  1973-02

Review 3.  [Immunologic phenomena in liver diseases: significance of mitochondrial antibodies].

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  Klin Wochenschr       Date:  1969-12-15

4.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

5.  Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.

Authors:  W Pernice; C P Sodomann; G Lüben; F R Seiler; H H Sedlacek
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

6.  Circulating HBsAg/IgG complexes in idiopathic chronic glomerulonephritis.

Authors:  S Y Hong; D H Yang; J M Park
Journal:  Korean J Intern Med       Date:  1991-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.